Factor XIII, clot structure, thrombosis

Thrombosis Research

Volumn 129, Issue 3, 2012, Pages 382-387

  Bagoly, Zsuzsa ^a   Koncz, Zsuzsa ^a   Hársfalvi, Jolán ^a   Muszbek, László ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

atherothrombotic disease; clot structure; factor XIII; factor XIII polymorphism; fibrin; venous thrombosis

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 13B; CALCIUM ION; ENZYME PRECURSOR; FIBRIN; LIPOPROTEIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; UROKINASE;

ALPHA CHAIN; BLEEDING TENDENCY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BRAIN ISCHEMIA; CORONARY ARTERY DISEASE; DOWN REGULATION; FIBRIN CLOT; FIBRIN FORMATION; FIBRIN POLYMERIZATION; FIBRINOLYSIS; GENE INTERACTION; GENOTYPE ENVIRONMENT INTERACTION; HEMOSTASIS; HUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ADHESION; THROMBOSIS; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ANIMALS; BLOOD COAGULATION; EVIDENCE-BASED MEDICINE; FACTOR XIII; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS;

EID: 84857788871     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.11.040     Document Type: Review

References (46)

1. I. Komaromi, Z. Bagoly, and L. Muszbek Factor XIII: novel structural and functional aspects J Thromb Haemost 9 2011 9 20
2. L. Muszbek, Z. Bereczky, Z. Bagoly, I. Komaromi, and E. Katona Factor XIII: a coagulation factor with multiple plasmatic and cellular functions Physiol Rev 91 2011 931 972
3. S.E. Iismaa, B.M. Mearns, L. Lorand, and R.M. Graham Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders Physiol Rev 89 2009 991 1023
4. M. Karimi, Z. Bereczky, N. Cohan, and L. Muszbek Factor XIII Deficiency Semin Thromb Hemost 35 2009 426 438
5. L. Muszbek, Z. Bagoly, A. Cairo, and F. Peyvandi Novel aspects of factor XIII deficiency Curr Opin Hematol 18 2011 366 372
6. S.T. Lord Molecular mechanisms affecting fibrin structure and stability Arterioscler Thromb Vasc Biol 31 2011 494 499
7. J.W. Weisel The mechanical properties of fibrin for basic scientists and clinicians Biophys Chem 112 2004 267 276 (Pubitemid 39574429)
8. W.W. Roberts, L. Lorand, and L.F. Mockros Viscoelastic properties of fibrin clots Biorheology 10 1973 29 42
9. J.P. Collet, H. Shuman, R.E. Ledger, S. Lee, and J.W. Weisel The elasticity of an individual fibrin fiber in a clot Proc Natl Acad Sci U S A 102 2005 9133 9137 (Pubitemid 40923529)
10. W. Liu, L.M. Jawerth, E.A. Sparks, M.R. Falvo, R.R. Hantgan, and R. Superfine Fibrin fibers have extraordinary extensibility and elasticity Science 313 2006 634 (Pubitemid 44201134)
11. Y. Sakata, and N. Aoki Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor J Clin Invest 65 1980 290 297 (Pubitemid 10159859)
12. K.N. Lee, K.W. Jackson, V.J. Christiansen, K.H. Chung, and P.A. McKee A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion Blood 103 2004 3783 3788 (Pubitemid 38596296)
13. Y. Sumi, Y. Ichikawa, Y. Nakamura, O. Miura, and N. Aoki Expression and characterization of pro alpha 2-plasmin inhibitor J Biochem 106 1989 703 707 (Pubitemid 19241842)
14. K.N. Lee, K.W. Jackson, V.J. Christiansen, C.S. Lee, J.G. Chun, and P.A. McKee Why alpha-antiplasmin must be converted to a derivative form for optimal function J Thromb Haemost 5 2007 2095 2104 (Pubitemid 47450029)
15. W.E. Holmes, H.R. Lijnen, and D. Collen Characterization of recombinant human alpha 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive site Biochemistry 26 1987 5133 5140 (Pubitemid 17134820)
16. S. Kimura, and N. Aoki Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor J Biol Chem 261 1986 15591 15595 (Pubitemid 17208788)
17. S.R. Fraser, N.A. Booth, and N.J. Mutch The antifibrinolytic function of factor XIII is exclusively expressed through alpha-antiplasmin cross-linking Blood 117 2011 6371 6374
18. L. Muszbek, Z. Bagoly, Z. Bereczky, and E. Katona The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis Cardiovasc Hematol Agents Med Chem 6 2008 190 205
19. Y. Sakata, J. Mimuro, and N. Aoki Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency Blood 63 1984 1393 1401 (Pubitemid 14120386)
20. K. Kolev, K. Tenekedjiev, E. Komorowicz, and R. Machovich Functional evaluation of the structural features of proteases and their substrate in fibrin surface degradation J Biol Chem 272 1997 13666 13675 (Pubitemid 27224800)
21. J. McDonagh, and H. Fukue Determinants of substrate specificity for factor XIII Semin Thromb Hemost 22 1996 369 376 (Pubitemid 27050705)
22. G.L. Reed, and A.K. Houng The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism Circulation 99 1999 299 304 (Pubitemid 29056374)
23. F.D. Rubens, D.W. Perry, M.W. Hatton, P.D. Bishop, M.A. Packham, and R.L. Kinlough-Rathbone Platelet accumulation on fibrin-coated polyethylene: role of platelet activation and factor XIII Thromb Haemost 73 1995 850 856
24. L. Muszbek, Z. Bereczky, Z. Bagoly, A.H. Shemirani, and E. Katona Factor XIII and atherothrombotic diseases Semin Thromb Hemost 36 2010 18 33
25. Z. Bereczky, and L. Muszbek Factor XIII and venous thromboembolism Semin Thromb Hemost 37 2011 305 314
26. Z. Bereczky, E. Balogh, E. Katona, I. Czuriga, I. Edes, and L. Muszbek Elevated factor XIII level and the risk of myocardial infarction in women Haematologica 92 2007 287 288 (Pubitemid 46852447)
27. V.G. Kalaria, W. Zareba, A.J. Moss, G. Pancio, V.J. Marder, and J.H. Morrissey Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators Am J Cardiol 85 2000 1401 1408 (Pubitemid 30336573)
28. A.H. Shemirani, E. Szomjak, Z. Csiki, E. Katona, Z. Bereczky, and L. Muszbek Elevated factor XIII level and the risk of peripheral artery disease Haematologica 93 2008 1430 1432
29. R.A. Ariens, H. Philippou, C. Nagaswami, J.W. Weisel, D.A. Lane, and P.J. Grant The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure Blood 96 2000 988 995 (Pubitemid 30616865)
30. I. Balogh, G. Szoke, L. Karpati, U. Wartiovaara, E. Katona, and I. Komaromi Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia Blood 96 2000 2479 2486
31. U. Wartiovaara, H. Mikkola, G. Szoke, G. Haramura, L. Karpati, and I. Balogh Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A Thromb Haemost 84 2000 595 600
32. B.C. Lim, R.A. Ariens, A.M. Carter, J.W. Weisel, and P.J. Grant Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk Lancet 361 2003 1424 1431 Correction in Lancet, 2003; 361: 2250 (Pubitemid 36515043)
33. H.P. Kohler, M.H. Stickland, N. Ossei-Gerning, A. Carter, H. Mikkola, and P.J. Grant Association of a common polymorphism in the factor XIII gene with myocardial infarction Thromb Haemost 79 1998 8 13 (Pubitemid 28037047)
34. Z. Voko, Z. Bereczky, E. Katona, R. Adany, and L. Muszbek Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis Thromb Haemost 97 2007 458 463 (Pubitemid 46437809)
35. A.P. Reiner, M.B. Frank, S.M. Schwartz, M.L. Linenberger, W.T. Longstreth, and G. Teramura Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women Br J Haematol 116 2002 376 382 (Pubitemid 34155511)
36. H.P. Kohler, M.W. Mansfield, P.S. Clark, and P.J. Grant Interaction between insulin resistance and factor XIII Val34Leu in patients with coronary artery disease Thromb Haemost 82 1999 1202 1203 (Pubitemid 29419748)
37. S.M. Boekholdt, M.S. Sandhu, N.J. Wareham, R. Luben, P.H. Reitsma, and K.T. Khaw Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study J Thromb Haemost 4 2006 2204 2209 (Pubitemid 44400299)
38. Z. Bereczky, E. Balogh, E. Katona, Z. Pocsai, I. Czuriga, and G. Szeles Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population Thromb Res 120 2007 567 573 (Pubitemid 47103195)
39. W. Renner, M. Brodmann, E. Pabst, O. Stanger, T.C. Wascher, and E. Pilger The V34L polymorphism of factor XIII and peripheral arterial disease Int Angiol 21 2002 53 57 (Pubitemid 34413654)
40. D.M. Pruissen, A.J. Slooter, F.R. Rosendaal, Y. van der Graaf, and A. Algra Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke Blood 111 2008 1282 1286 (Pubitemid 351213411)
41. A.J. Catto, H.P. Kohler, J. Coore, M.W. Mansfield, M.H. Stickland, and P.J. Grant Association of a common polymorphism in the factor XIII gene with venous thrombosis Blood 93 1999 906 908 (Pubitemid 29067855)
42. P.S. Wells, J.L. Anderson, D.K. Scarvelis, S.P. Doucette, and F. Gagnon Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis Am J Epidemiol 164 2006 101 109 (Pubitemid 43992174)
43. R. Gohil, G. Peck, and P. Sharma The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls Thromb Haemost 102 2009 360 370
44. C.Y. Vossen, and F.R. Rosendaal The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level J Thromb Haemost 3 2005 1102 1103 (Pubitemid 41632850)
45. N. Komanasin, A.J. Catto, T.S. Futers, A. van Hylckama Vlieg, F.R. Rosendaal, and R.A. Ariens A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis J Thromb Haemost 3 2005 2487 2496 (Pubitemid 41727166)
46. A.H. Shemirani, G. Haramura, Z. Bagoly, and L. Muszbek The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma Biochim Biophys Acta 1764 2006 1420 1423 (Pubitemid 44279571)